Asia Business News | Tuesday, May 13, 2008
email news alerts
RSS 2.0  
Biopharmaceutical company with a focus on neuroprotection and metabolism.
Company Fax +64 9 367 7186 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2005/02/03 
Company Homepage www.neurenpharma.com/
 
Stock Exchange Stock Code
ASXNEU
News Reader RSS   NEUREN PHARMACEUTICALS LIMITED
Drag Podcast Icon To iTunes - Podcast Download for NEUREN PHARMACEUTICALS LIMITED
 Neuren Pharmaceuticals Limited ASX: NEU - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO (FEB 14, 2007)